The latest research found that Chinese medicine can inhibit the transcriptional activity of NF-κB and the expression of NF-κB target gene chemokine CCL2, thereby inhibiting the production of pro-inflammatory factors and pro-fibrotic factors to achieve the effect of improving liver fibrosis [54, 55]. Here, NFKB1 is linked to Hepatic fibrosis.